Drug Profile
IDD 5
Alternative Names: Collidem; IDD-5Latest Information Update: 22 Feb 2010
Price :
$50
*
At a glance
- Originator IDM Pharma
- Developer Takeda America Holdings
- Class Cancer vaccines; Dendritic cell vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Colorectal cancer